List of Excipients in API methyldopa and hydrochlorothiazide
✉ Email this page to a colleague
Excipients in ANDA-approved (generic) drugs containing methyldopa and hydrochlorothiazide
| Company | Ingredient | NDC | Excipient |
|---|---|---|---|
| Mylan Pharmaceuticals Inc | methyldopa and hydrochlorothiazide | 0378-0507 | CELLULOSE, MICROCRYSTALLINE |
| Mylan Pharmaceuticals Inc | methyldopa and hydrochlorothiazide | 0378-0507 | CROSCARMELLOSE SODIUM |
| Mylan Pharmaceuticals Inc | methyldopa and hydrochlorothiazide | 0378-0507 | D&C YELLOW NO. 10 |
| >Company | >Ingredient | >NDC | >Excipient |
Detailed excipient profiles for methyldopa and hydrochlorothiazide
Excipient focus: CELLULOSE, MICROCRYSTALLINE
methyldopa and hydrochlorothiazide drug variants containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | methyldopa and hydrochlorothiazide | 0378-0507 |
| >Company | >Ingredient | >NDC |
methyldopa and hydrochlorothiazide drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: CROSCARMELLOSE SODIUM
methyldopa and hydrochlorothiazide drug variants containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | methyldopa and hydrochlorothiazide | 0378-0507 |
| >Company | >Ingredient | >NDC |
methyldopa and hydrochlorothiazide drug variants not containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: D&C YELLOW NO. 10
methyldopa and hydrochlorothiazide drug variants containing D&C YELLOW NO. 10
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | methyldopa and hydrochlorothiazide | 0378-0507 |
| >Company | >Ingredient | >NDC |
methyldopa and hydrochlorothiazide drug variants not containing D&C YELLOW NO. 10
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C BLUE NO. 1
methyldopa and hydrochlorothiazide drug variants containing FD&C BLUE NO. 1
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | methyldopa and hydrochlorothiazide | 0378-0507 |
| >Company | >Ingredient | >NDC |
methyldopa and hydrochlorothiazide drug variants not containing FD&C BLUE NO. 1
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C YELLOW NO. 6
methyldopa and hydrochlorothiazide drug variants containing FD&C YELLOW NO. 6
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | methyldopa and hydrochlorothiazide | 0378-0507 |
| >Company | >Ingredient | >NDC |
methyldopa and hydrochlorothiazide drug variants not containing FD&C YELLOW NO. 6
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE
methyldopa and hydrochlorothiazide drug variants containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | methyldopa and hydrochlorothiazide | 0378-0507 |
| >Company | >Ingredient | >NDC |
methyldopa and hydrochlorothiazide drug variants not containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
methyldopa and hydrochlorothiazide drug variants containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | methyldopa and hydrochlorothiazide | 0378-0507 |
| >Company | >Ingredient | >NDC |
methyldopa and hydrochlorothiazide drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POLYDEXTROSE
methyldopa and hydrochlorothiazide drug variants containing POLYDEXTROSE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | methyldopa and hydrochlorothiazide | 0378-0507 |
| >Company | >Ingredient | >NDC |
methyldopa and hydrochlorothiazide drug variants not containing POLYDEXTROSE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL
methyldopa and hydrochlorothiazide drug variants containing POLYETHYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | methyldopa and hydrochlorothiazide | 0378-0507 |
| >Company | >Ingredient | >NDC |
methyldopa and hydrochlorothiazide drug variants not containing POLYETHYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SILICON DIOXIDE
methyldopa and hydrochlorothiazide drug variants containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | methyldopa and hydrochlorothiazide | 0378-0507 |
| >Company | >Ingredient | >NDC |
methyldopa and hydrochlorothiazide drug variants not containing SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM LAURYL SULFATE
methyldopa and hydrochlorothiazide drug variants containing SODIUM LAURYL SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | methyldopa and hydrochlorothiazide | 0378-0507 |
| >Company | >Ingredient | >NDC |
methyldopa and hydrochlorothiazide drug variants not containing SODIUM LAURYL SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
methyldopa and hydrochlorothiazide drug variants containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | methyldopa and hydrochlorothiazide | 0378-0507 |
| >Company | >Ingredient | >NDC |
methyldopa and hydrochlorothiazide drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TRIACETIN
methyldopa and hydrochlorothiazide drug variants containing TRIACETIN
| Company | Ingredient | NDC |
|---|---|---|
| Mylan Pharmaceuticals Inc | methyldopa and hydrochlorothiazide | 0378-0507 |
| >Company | >Ingredient | >NDC |
methyldopa and hydrochlorothiazide drug variants not containing TRIACETIN
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
NCE-1 Patent Challenge Dates 2025 - 2026
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2025, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch